bf/NASDAQ:LXRX_icon.jpeg

NASDAQ:LXRX

Lexicon Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.43

06/11 22:31

Market Cap

589.23M

Beta: 1.33

Volume Today

4.08M

Avg: 593.73K

PE Ratio

−3.21

PFCF: −3.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
22.85M
-
130.01M
468.89%
83.34M
35.90%
90.33M
8.40%
63.21M
30.03%
322.07M
409.54%
24.00M
92.55%
298K
98.76%
139K
53.36%
1.20M
766.19%
31.08M
2,481.48%
cost of revenue
1.90M
-
2.49M
31.17%
3.23M
29.71%
1.93M
40.30%
85K
-
616K
624.71%
gross profit
22.85M
-
130.01M
468.89%
83.34M
35.90%
88.44M
6.12%
60.72M
31.34%
318.84M
425.12%
22.07M
93.08%
298K
98.65%
139K
53.36%
1.12M
705.04%
30.46M
2,622.52%
selling and marketing expenses
general and administrative expenses
19.41M
-
23.84M
22.79%
43.04M
80.59%
66.20M
53.80%
63.75M
3.70%
48.08M
-
selling general and administrative expenses
19.41M
-
23.84M
22.79%
43.04M
80.59%
66.20M
53.80%
63.75M
3.70%
56.84M
10.85%
47.23M
16.90%
32.34M
31.52%
48.08M
48.67%
113.98M
137.05%
143.10M
25.55%
research and development expenses
89.28M
-
95.19M
6.62%
178.15M
87.16%
156.81M
11.98%
100.24M
36.07%
91.92M
8.30%
153.62M
67.12%
55.05M
64.17%
52.82M
4.05%
58.89M
11.49%
84.48M
43.46%
other expenses
2.25M
-
572K
74.63%
2.29M
300.87%
1.95M
14.78%
28.64M
-
1.60M
94.41%
cost and expenses
108.69M
-
119.02M
9.51%
221.19M
85.84%
224.91M
1.68%
166.49M
25.98%
151.99M
8.71%
202.78M
33.42%
87.39M
56.91%
100.90M
15.46%
172.95M
71.41%
228.20M
31.94%
operating expenses
108.69M
-
119.02M
9.51%
221.19M
85.84%
223.02M
0.82%
164.00M
26.46%
148.76M
9.29%
200.85M
35.02%
87.39M
56.49%
100.90M
15.46%
172.87M
71.33%
227.58M
31.65%
interest expense
2.25M
-
6.72M
198.36%
6.57M
2.31%
6.98M
6.35%
20.78M
197.49%
20.68M
0.49%
14.54M
29.66%
802K
94.49%
2.78M
246.63%
11.59M
316.87%
15.58M
34.43%
ebitda
-83.58M
-
11.56M
113.84%
-135.56M
1,272.30%
-132.63M
2.17%
-99.77M
24.77%
173.43M
273.83%
-176.02M
201.49%
-86.96M
50.60%
-99.16M
14.04%
-171.75M
73.20%
-184.29M
7.30%
operating income
-100.37M
-
1.47M
101.46%
-137.16M
9,442.98%
-136.68M
0.35%
-103.28M
24.44%
141.44M
236.95%
-178.78M
226.40%
-87.09M
51.29%
-100.76M
15.70%
-171.75M
70.45%
-197.12M
14.77%
depreciation and amortization
1.93M
-
727K
62.29%
2.06M
182.81%
3.40M
65.32%
3.68M
8.36%
31.99M
768.53%
2.77M
91.35%
134K
95.16%
1.60M
1,091.04%
534K
-
total other income expenses net
-14.53M
-
-9.52M
34.45%
703K
107.38%
-2.10M
398.86%
-17.27M
721.94%
-17.33M
0.33%
120.21M
793.82%
-668K
100.56%
-1.18M
77.25%
-3.86M
225.76%
-3.29M
14.80%
income before tax
-100.36M
-
-4.68M
95.33%
-141.43M
2,920.70%
-141.71M
0.20%
-120.55M
14.93%
124.12M
202.96%
-58.57M
147.19%
-87.76M
49.82%
-101.94M
16.16%
-175.61M
72.26%
-200.40M
14.12%
income tax expense
-70K
-
6.00M
8,664.29%
4.51M
24.75%
-12.66M
380.67%
3.51M
127.71%
-6.01M
271.44%
11.61M
293.05%
510K
95.61%
1.18M
132.16%
net income
-100.29M
-
-4.68M
95.33%
-141.43M
2,920.70%
-129.05M
8.75%
-120.55M
6.59%
130.13M
207.95%
-70.18M
153.93%
-88.27M
25.77%
-103.13M
16.84%
-175.61M
70.28%
-200.40M
14.12%
weighted average shs out
76.35M
-
103.59M
35.68%
103.86M
0.26%
105.24M
1.32%
105.83M
0.56%
106.22M
0.37%
110.84M
4.35%
145.65M
31.41%
165.73M
13.79%
221.13M
33.43%
320.03M
44.73%
weighted average shs out dil
76.35M
-
103.59M
35.68%
103.86M
0.26%
105.24M
1.32%
105.83M
0.56%
116.75M
10.32%
110.84M
5.06%
145.65M
31.41%
165.73M
13.79%
221.13M
33.43%
320.03M
44.73%
eps
-1.31
-
-0.05
96.55%
-1.36
2,908.85%
-1.23
9.56%
-1.14
7.32%
1.23
207.89%
-0.63
151.22%
-0.61
3.17%
-0.62
1.64%
-0.79
27.42%
-0.63
20.25%
epsdiluted
-1.31
-
-0.05
96.55%
-1.36
2,908.85%
-1.23
9.56%
-1.14
7.32%
1.16
201.75%
-0.63
154.31%
-0.61
3.17%
-0.62
1.64%
-0.79
27.42%
-0.63
20.25%

All numbers in USD (except ratios and percentages)